Paris and Boston, January 62016 - NEOVACS (Alternext Paris: ALNEV),has concluded an agreement which provides non-dilutive funding of five million euros for over the next four years, in the form of grants and repayable advances.

This funding decision made by The General Commission for Investment and operated by Bpifrance*, is part of the program:«PIAVE- Industrial project for the future» and will be used to finalize clinical development and to initiate the industrialization process for the therapeutic vaccine IFN Kinoid.

Neovacs SA issued this content on 2016-01-06 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-06 10:55:25 UTC

Original Document: http://neovacs.fr/neovacs-secures-e5-million-from-the-public-funding-program-investments-for-the-future/